JP2005506995A5 - - Google Patents

Download PDF

Info

Publication number
JP2005506995A5
JP2005506995A5 JP2003537569A JP2003537569A JP2005506995A5 JP 2005506995 A5 JP2005506995 A5 JP 2005506995A5 JP 2003537569 A JP2003537569 A JP 2003537569A JP 2003537569 A JP2003537569 A JP 2003537569A JP 2005506995 A5 JP2005506995 A5 JP 2005506995A5
Authority
JP
Japan
Prior art keywords
composition
pain
lidocaine
local anesthetic
related pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003537569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506995A (ja
Filing date
Publication date
Priority claimed from US10/045,341 external-priority patent/US20030124174A1/en
Application filed filed Critical
Publication of JP2005506995A publication Critical patent/JP2005506995A/ja
Publication of JP2005506995A5 publication Critical patent/JP2005506995A5/ja
Withdrawn legal-status Critical Current

Links

JP2003537569A 2001-10-25 2002-10-23 非神経障害性疼痛を処置するための方法 Withdrawn JP2005506995A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/045,341 US20030124174A1 (en) 2001-10-25 2001-10-25 Method for treating non-neuropathic pain
PCT/US2002/034077 WO2003035000A2 (en) 2001-10-25 2002-10-23 Method for treating non-neuropathic pain

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2009286980A Division JP2010065059A (ja) 2001-10-25 2009-12-17 非神経障害性疼痛を処置するための方法
JP2010122735A Division JP2010202663A (ja) 2001-10-25 2010-05-28 非神経障害性疼痛を処置するための方法

Publications (2)

Publication Number Publication Date
JP2005506995A JP2005506995A (ja) 2005-03-10
JP2005506995A5 true JP2005506995A5 (https=) 2006-01-05

Family

ID=21937331

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003537569A Withdrawn JP2005506995A (ja) 2001-10-25 2002-10-23 非神経障害性疼痛を処置するための方法
JP2009286980A Pending JP2010065059A (ja) 2001-10-25 2009-12-17 非神経障害性疼痛を処置するための方法
JP2010122735A Pending JP2010202663A (ja) 2001-10-25 2010-05-28 非神経障害性疼痛を処置するための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009286980A Pending JP2010065059A (ja) 2001-10-25 2009-12-17 非神経障害性疼痛を処置するための方法
JP2010122735A Pending JP2010202663A (ja) 2001-10-25 2010-05-28 非神経障害性疼痛を処置するための方法

Country Status (6)

Country Link
US (2) US20030124174A1 (https=)
EP (1) EP1446087A4 (https=)
JP (3) JP2005506995A (https=)
CN (1) CN1571656B (https=)
CA (1) CA2464067C (https=)
WO (1) WO2003035000A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
US20030118632A1 (en) * 2001-12-26 2003-06-26 Larry Caldwell Methods and compositions for treating carpal tunnel syndrome
DE10332487A1 (de) * 2003-07-16 2005-02-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
EP1696877A4 (en) * 2003-11-13 2010-06-09 Gen Hospital Corp PROCESS FOR PAIN TREATMENT
US20050112183A1 (en) * 2003-11-25 2005-05-26 Galer Bradley S. Compositions and methods for treating neuropathic sensory loss
US8569277B2 (en) 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
WO2006036936A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
JP4921739B2 (ja) * 2005-08-10 2012-04-25 久光製薬株式会社 皮膚刺激を低減した貼付剤
US7592458B2 (en) * 2006-07-21 2009-09-22 Wright George E Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
US8549015B2 (en) * 2007-05-01 2013-10-01 Giancarlo Barolat Method and system for distinguishing nociceptive pain from neuropathic pain
CA2703872C (en) * 2007-11-11 2015-11-03 Medrx Co., Ltd. Lidocaine tape preparation
US20090297591A1 (en) * 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
US9012477B2 (en) * 2009-01-06 2015-04-21 Nuvo Research Inc. Method of treating neuropathic pain
US20110086913A1 (en) * 2009-04-01 2011-04-14 Jie Zhang Methods for treating myofascial, muscle, and/or back pain
US9186334B2 (en) 2009-05-04 2015-11-17 Nuvo Research Inc. Heat assisted lidocaine and tetracaine for transdermal analgesia
CN102427792A (zh) * 2009-05-04 2012-04-25 扎斯制药公司 治疗与神经瘤、神经卡压及其他病况相关联的疼痛的方法
US20110008413A1 (en) * 2009-07-08 2011-01-13 Msk Pharma, Llc Compositions and Methods of Topical Drug Delivery for the Treatment of Carpal Tunnel Syndrome
CN102834096A (zh) 2010-01-14 2012-12-19 卢福研究公司 用于疼痛控制的固态成型局部麻醉制剂
AU2016259348B9 (en) * 2010-04-13 2018-11-29 Relmada Therapeutics, Inc. Dermal pharmaceutical compositions of 1-Methyl-2',6' pipecoloxylidide and method of use
JP5927506B2 (ja) 2010-04-13 2016-06-01 レルマダ セラピューティクス、インク． １−メチル−２’，６’−ピペコロキシリダイドの皮膚医薬組成物および使用方法
US12201676B2 (en) 2011-03-18 2025-01-21 Dr Healthcare España, S.L. Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
ES2387973B1 (es) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Composiciones tópicas que contienen diaminooxidasa para el tratamiento o la prevención de enfermedades asociadas a un nivel de histamina elevada que comportan un aumento del dolor.
ES2388395B1 (es) * 2011-03-18 2013-10-01 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención de la fibromialgia o la fatiga crónica.
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
BR112013028802B1 (pt) 2011-05-10 2021-10-26 Itochu Chemical Frontier Corporation Curativo adesivo não-aquoso
ES3034911T3 (en) 2011-05-10 2025-08-26 Itochu Chemical Frontier Corp Non-aqueous patch
LT2823815T (lt) 2011-09-27 2018-08-27 Itochu Chemical Frontier Corporation Nevandeninis pleistras
EP2822641B1 (en) * 2012-03-08 2019-06-19 SPR Therapeutics, Inc. System for treatment of pain related to limb joint replacement surgery
ES2426539B1 (es) 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
CN108024979A (zh) * 2015-08-24 2018-05-11 伊藤忠富隆达化工株式会社 包含利多卡因的非水性贴剂
WO2017151806A1 (en) 2016-03-01 2017-09-08 Kitotech Medical, Inc. Microstructure-based systems, apparatus, and methods for wound closure
WO2018160797A1 (en) * 2017-03-01 2018-09-07 Arctic Fox Biomedical, Inc. Cryotherapies
WO2021168345A1 (en) * 2020-02-19 2021-08-26 Kitotech Medical, Inc. Microstructure systems and methods for pain treatment
US20250090487A1 (en) * 2021-09-09 2025-03-20 Andros Pharmaceuticals Co., Ltd. Topical anesthetic agent-clay composite compositions

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713617L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Antitranspirationsmedel
US4460368A (en) * 1981-10-29 1984-07-17 Almedco, Inc. Trans-dermal medication system
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
US4963345A (en) * 1988-07-18 1990-10-16 Forrest Kim K Injectable local anesthetic antidote
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
CA1338779C (en) * 1989-03-17 1996-12-10 Harry Hind Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
US5411738A (en) * 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
MX21452A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
US5139786A (en) * 1989-07-07 1992-08-18 Ciba-Geigy Corporation Topical formulations
US5447947A (en) * 1990-02-26 1995-09-05 Arc 1 Compositions and methods of treatment of sympathetically maintained pain
JP3004769B2 (ja) * 1990-05-30 2000-01-31 フェリック株式会社 温熱治療用構造物
KR100198044B1 (ko) * 1991-05-13 1999-06-15 아이 에이 호틴 이부프로펜 염을 포함하는 약제학적 조성물
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
WO1994000484A1 (en) * 1992-06-22 1994-01-06 Young Henry E Scar inhibitory factor and use thereof
IL106484A (en) * 1992-07-31 1998-08-16 Lai John Compositions for therapeutic and anaesthetic treatment and the use thereof
US5462743A (en) * 1992-10-30 1995-10-31 Medipro Sciences Limited Substance transfer system for topical application
ES2160623T3 (es) * 1992-12-31 2001-11-16 Sunkyong Ind Ltd Composiciones farmaceuticas mejoradas para la penetracion en la piel de piroxicam.
WO1994023748A1 (en) * 1993-04-08 1994-10-27 The University Of Queensland Administration of vaso-active agent and therapeutic agent
US5478566A (en) * 1993-09-29 1995-12-26 Loria; Roger M. Stimulation of cytokine production
US5376662A (en) * 1993-12-08 1994-12-27 Ockert; David M. Method of attenuating nerve injury induced pain
FR2713637B1 (fr) * 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés bi-aromatiques dérivés d'amide, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2713635B1 (fr) * 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
JPH09509156A (ja) * 1994-02-03 1997-09-16 ケンブリッジ・ニューロサイエンス・インコーポレーテッド 治療用グアニジン類
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US5536263A (en) * 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
US6190691B1 (en) * 1994-04-12 2001-02-20 Adolor Corporation Methods for treating inflammatory conditions
FR2719041B1 (fr) * 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2719043B1 (fr) * 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés bicycliques-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
SE9402453D0 (sv) * 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation
US5612382A (en) * 1994-07-15 1997-03-18 Frances B. Fike Composition for percutaneous absorption of pharmaceutically active ingredients
DE4426625A1 (de) * 1994-07-27 1996-03-14 Schering Ag 2-Phenylindole, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
DE69513484T2 (de) * 1994-10-04 2000-03-16 Centre International De Recherches Dermatologiques Galderma (Cird Galderma) Neue, von Dibenzofuran abgeleitete Verbindungen und pharmazeutische und kosmetische Zusammensetzungen, die sie enthalten.
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
FR2730995B1 (fr) * 1995-02-23 1997-04-04 Cird Galderma Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US6166085A (en) * 1995-04-14 2000-12-26 The Regents Of The University Of California Method of producing analgesia
US5849737A (en) * 1995-04-14 1998-12-15 The Regents Of The University Of California Compositions and methods for treating pain
US5948389A (en) * 1995-06-07 1999-09-07 El Khoury & Stein, Ltd. Method of enhancing the analgesic efficacy of locally and topically administered opioids and other local anesthetics
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
US5795864A (en) * 1995-06-27 1998-08-18 Neurex Corporation Stable omega conopetide formulations
DE19526031A1 (de) * 1995-07-17 1997-01-23 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Rückenschmerz und Muskelverspannung
US5667799A (en) * 1995-10-30 1997-09-16 Caldwell; Larry J. Method for treating headache pain with topical local anesthetic compositions
US6248788B1 (en) * 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US5612051A (en) * 1995-11-17 1997-03-18 Yue; Samuel K. Method of treating involuntary muscle dysfunction with relaxin hormone
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
ES2230571T3 (es) * 1995-12-28 2005-05-01 Mitsubishi Pharma Corporation `composicion farmaceutica destinada para la administracion topica que comprende el 2-amino-2-(2-(4-octilfenil)etil) propan-1,3-diol para el tratamiento de las enfermedades causadas por una alteracion inmunitaria.
US5688830A (en) * 1996-01-25 1997-11-18 Syntex (U.S.A.) Inc. Treatment of neuropathic pain
US5869533A (en) * 1996-04-23 1999-02-09 Holt; Stephen D. Non-irritating capsaicin formulations and applicators therefor
US5856361A (en) * 1996-04-23 1999-01-05 Medical Merchandising, Inc. Pain reliever and method of use
JPH09315964A (ja) * 1996-05-27 1997-12-09 Chinhin Boku 肩こり・五十肩治療用貼付剤
KR100213465B1 (ko) * 1996-11-01 1999-08-02 최좌진 케토프로펜 패취 조성물
US5709878A (en) * 1996-08-02 1998-01-20 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US6245340B1 (en) * 1996-12-03 2001-06-12 Parvin Youssefyeh Method of improving the immune response and compositions therefor
US5985933A (en) * 1997-01-24 1999-11-16 Celgene Corporation Methods for treating central and peripheral nerve pain
US6113940A (en) * 1997-03-03 2000-09-05 Brooke; Lawrence L. Cannabinoid patch and method for cannabis transdermal delivery
US5976547A (en) * 1997-04-22 1999-11-02 Niblick Pharmaceuticals, Inc. Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
US6132762A (en) * 1997-05-05 2000-10-17 Cristobal; Walter Transcutaneous application of marijuana
US5935932A (en) * 1997-06-13 1999-08-10 University Technology Corporation Bradykinin antagonists containing pentafluorophenylalanine
FR2764604B1 (fr) * 1997-06-13 1999-09-10 Cird Galderma Composes bi-aromatiques relies par un radical propynylene ou allenylene et compositions pharmaceutiques et cosmetiques les contenant
US5885597A (en) * 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
ES2241178T3 (es) * 1997-10-27 2005-10-16 Eli Lilly And Company Profarmacos de ester de morlino-n-etilo de inhibidores indolicos de spla 2.
US5869090A (en) * 1998-01-20 1999-02-09 Rosenbaum; Jerry Transdermal delivery of dehydroepiandrosterone
US5900249A (en) * 1998-02-09 1999-05-04 Smith; David J. Multicomponent pain relief topical medication
US6103771A (en) * 1998-03-20 2000-08-15 Caldwell Galer Incorporated Method of treating neuroma pain
AR014809A1 (es) * 1998-04-03 2001-03-28 Advanced Medicine Inc Compuestos multiligazon, composicion farmaceutica, metodo para prepara dichos compuestos y uso de dichos compuestos para preparar medicamentos
US6211171B1 (en) * 1998-05-19 2001-04-03 Dalhousie University Use of antidepressants for local analgesia
EP1182193A4 (en) * 1999-04-09 2002-09-11 Mochida Pharm Co Ltd REMEDIES FOR NEUROGENIC PAIN
DE60022333T2 (de) * 1999-04-09 2006-07-06 Euro-Celtique S.A. Natrium kanalblocker zusammensetzungen und deren verwendung
US6140327A (en) * 1999-05-12 2000-10-31 Eli Lilly And Company Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
US6197823B1 (en) * 1999-09-29 2001-03-06 Medical Merchandising, Inc. Pain reliever and method of use
EP1216243A1 (en) * 1999-10-01 2002-06-26 Advanced Medicine, Inc. Quinazolinones and analogues and their use as local anesthetics
US6147102A (en) * 1999-10-26 2000-11-14 Curatek Pharmaceuticals Holding, Inc. Clonidine preparations
US7018647B1 (en) * 1999-12-27 2006-03-28 Teikoku Seiyaku Co., Ltd Patches for external use
AR029489A1 (es) * 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
US7687080B2 (en) * 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
US20050112183A1 (en) * 2003-11-25 2005-05-26 Galer Bradley S. Compositions and methods for treating neuropathic sensory loss

Similar Documents

Publication Publication Date Title
JP2005506995A5 (https=)
Minville et al. Opioid-induced hyperalgesia in a mice model of orthopaedic pain: preventive effect of ketamine
ATE423560T1 (de) Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
MX9200992A (es) Composicion farmaceutica que tiene como ingrediente activo 3-[2-(dimetilamino)etil]-n-metil-1h-indol-5-metanosulfonamida y procedimiento para su preparacion.
CA2464067A1 (en) Method for treating non-neuropathic pain
SI1587506T1 (sl) Zdravljenje s kapsaicinom
KR980000447A (ko) 미르타자핀과 하나 이상의 선택적인 세로토닌 재이용 저해제로 이루어진 약학 조성물
AU2003216321A1 (en) Tamper-resistant transdermal opioid delivery devices
BRPI0415649A (pt) método para tratar, prevenir, modificar ou administrar dor, e, composição farmacêutica
NO20045240L (no) Transepikutan administrasjonsform for a behandle restless legs syndromet
BR0315573A (pt) Método para tratar, prevenir, controlar e/ou modificar dor em um paciente e composição farmacêutica
EA200600817A1 (ru) Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты)
EP0888054A4 (en) Targeted site specific drug delivery compositions and method of use
WO2005081742A3 (en) Testosterone oral dosage formulations and associated methods
IS2630B (is) Meðferð á fráhvarfseinkennum
BR0315593A (pt) Método de tratar, prevenir, modificar ou controlar dor e composição farmacêutica
AR045783A1 (es) Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
ATE414522T1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
JP2003528919A5 (https=)
Valen et al. Evidence supporting the use of physical modalities in the treatment of upper extremity musculoskeletal conditions
ATE310509T1 (de) Methode zur behandlung eines analgesiebedürftigen patienten
US4312865A (en) Medication having penetration through cutaneous surfaces into articular and muscular areas
NZ594154A (en) Transdermal administration of buprenorphine for preoperative treatment of post operative pain
BR0315609A (pt) Método de tratar, prevenir, modificar ou controlar dor e composição farmacêutica
Farooq et al. Perceived efficacy and risks of infection following intra-articular injections: a survey of orthopaedic surgeons